How Driver Mutation Research Is Advancing MPN Treatments

preview_player
Показать описание
How do driver mutations affect MPN care? MPN researcher Dr. Gabriela Hobbs shares an update on what’s being learned about the JAK mutation and how researchers are working towards targeted therapy for MPNs.

  1. Patient Empowerment Network
  2. Dr. Gabriela Hobbs
  3. MPN
  4. Myeloproliferative Neoplasm
  5. Polycythemia Vera
  6. Myelofibrosis
Рекомендации по теме
How Driver Mutation 0:03:03

How Driver Mutation Research Is Advancing MPN Treatments

Driver mutation lung 0:37:23

Driver mutation lung cancer

What are driver 0:01:30

What are driver mutations vs passenger mutations? #myeloma

What Are The 0:05:41

What Are The Driver Mutations For My Cancer?

Shaping the Future: 0:00:20

Shaping the Future: Precision Oncology and the Quest for Driver Mutations

The Role of 0:05:29

The Role of Driver Mutations in NSCLC Treatment - 2022 Program: LCVL

Heterogeneity of NSCLC 0:16:35

Heterogeneity of NSCLC and precipitating oncogenic driver mutations

New cancer-driving mutation 0:03:32

New cancer-driving mutation discovered in the “dark matter” of the cancer genome

Surgery to prevent 1:01:10

Surgery to prevent ovarian cancer

Genomic Sequencing and 0:01:51

Genomic Sequencing and Identifying Driver Mutations in AML and MDS

DriveRank: Discovering Patient-Specific 0:19:44

DriveRank: Discovering Patient-Specific Driver Mutations

Identification of Driver 0:03:09

Identification of Driver Mutations in Transbronchial Needle Aspirates of Suspicious Lung Nodules

Pathogenesis and driver 0:05:16

Pathogenesis and driver mutations in SM-AHN

Who’s Driving Treatment? 0:14:06

Who’s Driving Treatment? Two Co-Occurring Driver Mutations in Primary Lung Adenocarcinoma

Driver mutations implicated 0:01:59

Driver mutations implicated in MPNs

Understanding Genetic Mutations 0:05:10

Understanding Genetic Mutations in MDS

High-Throughput Somatic Variant 0:17:36

High-Throughput Somatic Variant Impact Phenotyping Using Gene Expression Signatures - Angela Brooks

What is the 0:01:00

What is the PTCH1 mutation?

Extreme Rare Mutations 0:18:41

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

Driver Mutations in 0:03:03

Driver Mutations in Advanced Cholangiocarcinoma

The Future of 0:06:04

The Future of Driver Mutations in NSCLC

Timing of driver 0:04:50

Timing of driver mutations and clonal dynamics in MPNs: a new paradigm for blood cancer development

Why the Somatic 0:00:41

Why the Somatic Mutation Theory is Failing Patients

Identifying prognostic constellations 0:06:01

Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelody...